Should all patients stay on continuous T-DXd — or can some safely de-escalate?
This clip explores induction strategies, maintenance therapy, ctDNA, and how personalization may define the next era of HER2+ mBC.
Beyond the Induction Phase: Can We De-Escalate After DB09?
You may also like
Recommended Videos
